Skip to content
Screener

AtriCure ATRC Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B-0.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Boston Scientific logo
Boston ScientificBSX
1.5B-1.3%
Medtronic logo
MedtronicMDT
1.3B-0.1%
ITG
Integer HoldingsITGR
34.4M+1.5%
AngioDynamics logo
AngioDynamicsANGO
41.5M+1.6%

Other financials

Income statement

See full
Revenue$153.6M+12.8%
Gross profit$118.6M+16.9%
Operating income$9.7M+256%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total equity$516.4M+11.2%
Total assets$676.6M+11.1%

Cash flow

See full
Operating cash flow$22.2M+2.7%
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.01B+20.0%
Enterprise value$1.92B+17.3%
P/E770.8×
P/S3.5×+0.2×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Diluted net income (loss) per share$0.18$(0.13)$0.18$(0.27)
Weighted average shares outstanding
Basic48,66747,72148,50147,557
Diluted48,86847,72149,09447,557
Comprehensive income (loss):
Foreign currency translation adjustment(126)979(465)1,784
Net income (loss)8,955(6,190)9,063(12,937)
Comprehensive income (loss), net of tax$8,829$(5,211)$8,598$(11,153)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's shares (diluted)?
AtriCure (ATRC) reported shares (diluted) of 48.9M in Q2 2026.
How has AtriCure's shares (diluted) changed year-over-year?
AtriCure's shares (diluted) increased by 2.4% year-over-year, from 47.7M to 48.9M.
What is the long-term trend for AtriCure's shares (diluted)?
Over 4 years (2021 to 2025), AtriCure's shares (diluted) has grown at a 1.2% compound annual growth rate (CAGR), from 181.8M to 190.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about AtriCure's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude